Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
United Therapeutics Corporation - Common Stock
(NQ:
UTHR
)
482.91
+1.95 (+0.41%)
Streaming Delayed Price
Updated: 2:09 PM EST, Dec 4, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about United Therapeutics Corporation - Common Stock
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at Upcoming Scientific Meetings
April 18, 2023
From
United Therapeutics Corporation
Via
Business Wire
Analyst Expectations for United Therapeutics's Future
↗
April 10, 2023
Via
Benzinga
This Foreboding Sign Looms Over United Therapeutics's Chart
↗
April 05, 2023
Via
Benzinga
United Therapeutics Corporation to Present at the Oppenheimer 33rd Annual Healthcare Conference
March 06, 2023
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation to Present at the Cowen 43rd Annual Health Care Conference
February 28, 2023
From
United Therapeutics Corporation
Via
Business Wire
Earnings Outlook For United Therapeutics
↗
February 21, 2023
Via
Benzinga
Analyst Ratings for United Therapeutics
↗
January 11, 2023
Via
Benzinga
Morgan Stanley Maintains Overweight Rating for United Therapeutics: Here's What You Need To Know
↗
December 06, 2022
Via
Benzinga
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2022 Financial Results
February 22, 2023
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation to Report Fourth Quarter and Full Year 2022 Financial Results Before the Market Opens on Wednesday, February 22, 2023
February 15, 2023
From
United Therapeutics Corporation
Via
Business Wire
Want To Copy 'Master Trader' Nancy Pelosi's Investments? There's An ETF For That. Here Are The Holdings
↗
February 07, 2023
Subversive Capital launched two new ETFs Tuesday that offer investors the chance to mirror the trades being made by members of Congress.
Via
Benzinga
Expert Ratings for United Therapeutics
↗
December 05, 2022
Via
Benzinga
6 Analysts Have This to Say About United Therapeutics
↗
December 05, 2022
Via
Benzinga
Earnings Scheduled For February 22, 2023
↗
February 22, 2023
Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022.
Via
Benzinga
3 Biotech Companies to Watch in 2023
↗
January 06, 2023
These biotech companies to watch are remarkably strong businesses that offer healthy upside potential as we head into a new year.
Via
InvestorPlace
Crocs, Lamb Weston And These 3 Stocks Insiders Are Selling
↗
January 06, 2023
The Nasdaq Composite dropped around 150 points on Thursday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Alphabet And These 2 Healthcare Stocks Insiders Are Selling
↗
January 04, 2023
The Nasdaq Composite dropped around 80 points on the first trading day of 2023. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
United Therapeutics Corporation to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 02, 2023
From
United Therapeutics Corporation
Via
Business Wire
Should SMLF Be On Your Investing Radar?
↗
December 26, 2022
Sitting at a market capitalization below $2 billion, small cap companies tend to be high-potential stocks compared to their large and mid-cap counterparts but come with higher risks.
Via
Talk Markets
Buy/Sell: Wall Street's Top 10 Stock Calls This Week - Saturday, Dec. 10
↗
December 10, 2022
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street’s best analysts during the week of Dec. 5-9, 2022.
Via
Talk Markets
Our 7 Top Biotech Stock Picks for 2023
↗
December 09, 2022
Following the devastation of Covid-19, there’s greater interest toward medical innovations, thus bolstering biotech stock picks for 2023.
Via
InvestorPlace
United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2023
December 08, 2022
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics, Super Micro Computer, Novo Nordisk And Other Big Gainers From Wednesday
↗
November 03, 2022
U.S. stocks closed lower on Wednesday, with the Dow Jones dropping more than 500 points. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022
↗
December 06, 2022
Via
Benzinga
Recap: United Therapeutics Q3 Earnings
↗
November 02, 2022
United Therapeutics (NASDAQ:UTHR) reported its Q3 earnings results on Wednesday, November 2, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 5, 2022
↗
December 05, 2022
Via
Benzinga
United Therapeutics Corporation Reports Third Quarter 2022 Financial Results
November 02, 2022
From
United Therapeutics Corporation
Via
Business Wire
Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday
↗
November 03, 2022
Gainers Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after reporting Q3 results.
Via
Benzinga
Why Benefitfocus Shares Are Trading Higher By Around 48%? Here Are 64 Stocks Moving In Wednesday's Mid-Day Session
↗
November 02, 2022
Gainers Starry Group Holdings, Inc. (NYSE: STRY) gained 56% to $0.2808 after reporting Q3 results.
Via
Benzinga
Earnings Scheduled For November 2, 2022
↗
November 02, 2022
Companies Reporting Before The Bell • Nomura Holdings (NYSE:NMR) is likely to report earnings for its second quarter.
Via
Benzinga
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.